Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center.

ABSTRACT:

SUBMITTER: Borogovac A 

PROVIDER: S-EPMC8995917 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature